Christopher Cogle | Research | University of Florida

Skip to main content All experts

ACT PRG DIR & PROF

MD-MEDICINE

Orcid identifier0000-0001-5422-6863 (opens in a new tab)⁠

ACT PRG DIR & PROF
MD-MEDICINE

christopher.cogle@medicine.ufl.edu (opens in a new tab)

http://www.cogle.com/ (opens in a new tab)⁠

sort by:

GRANT
Tobacco Control Coalition Building Training
Florida Department of Health9 Jun 2026 - 30 Jun 2026
Expired
GRANT
Health Policy Training in Tobacco Prevention and Control
Florida Department of Health16 Apr 2026 - 30 Jun 2026
Expired
GRANT
Chief Medical Officer for Florida Medicaid, Agency for Health Care Administration
Agency for Health Care Administration11 Dec 2025 - 14 Dec 2027
Active
GRANT
FSCDR Contract
Foundation for Sickle Cell Disease Research1 Oct 2025 - 1 Apr 2026
Expired
GRANT
FSCDR Contract
Foundation for Sickle Cell Disease Research1 Oct 2025 - 7 Jul 2026
Expired
GRANT
Foundation for Sickle Cell Disease Research (FSCDR) For the SCD
Foundation for Sickle Cell Disease Research13 Mar 2025 - 7 Jul 2025
Expired
GRANT
OneFlorida+ Clinical Research Network Phase 4
Patient-Centered Outcomes Research Institute1 Jan 2025 - 31 Dec 2028
Active
GRANT
Health Policy Training in Tobacco Prevention and Control
Florida Department of Health1 Jul 2024 - 30 Jun 2025
Expired
GRANT
Blood Disorder Program: Prevention, Surveillance, and Research
Centers for Disease Control and Prevention10 May 2024 - 29 Sep 2026
Active
GRANT
Health Policy Training in Tobacco Prevention and Control
Florida Department of Health12 Apr 2024 - 30 Jun 2024
Expired
GRANT
Chief Medical Officer for Florida Medicaid, Agency for Health Care Administration
Agency for Health Care Administration15 Dec 2023 - 14 Dec 2025
Expired
GRANT
Health Policy Training in Tobacco Prevention and Control
Florida Department of Health30 Sep 2022 - 30 Jun 2023
Expired
GRANT
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches among Underserved Patients in Primary Care
Patient-Centered Outcomes Research Institute1 May 2022 - 30 Jul 2029
Active
GRANT
AHCA contract for CMO
Agency for Health Care Administration29 Mar 2021 - 13 Dec 2023
Expired
GRANT
Health Policy Training in Tobacco Prevention and Cessation
Florida Department of Health1 Feb 2021 - 30 Jun 2021
Expired
GRANT
FLDOH PO - 2021-2022 - Educating Community Leaders about Tobacco Regulation##########
Florida Department of Health7 Jan 2021 - 30 Jun 2022
Expired
GRANT
Targeting MDS with a BiTE
Oxnard Foundation1 Jul 2020 - 30 Jun 2023
Expired
GRANT
PHASE 1/1B OPEN-LABEL, DOSE-ESCALATION STUDY OF APVO436 IN PATIENTS WITH RELAPSED OR REFRACTORY AML OR HIGH-GRADE MDS
Aptevo Research and Development9 Mar 2020 - 7 Sep 2023
Closed
GRANT
LLS funding for Improving risk assessment of AML with a precision genomic strategy to assess mutation clearance
Blood Cancer United6 Feb 2020 - 19 Sep 2024
Closed
GRANT
Pilot Study of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes
Celgene Corporation26 Jun 2018 - 25 Jun 2019
Expired
GRANT
The Harry T. Mangurian, Jr. Foundation - Support for the Study of Therapy Resistant Leukemia
Harry T Mangurian Jr Foundation1 Nov 2017 - 31 Oct 2022
Expired
GRANT
A Phase 3, Multicenter, Open-Label, Randomized Study Comparing the Efficacy and Safety of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects with Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Celgene Corporation13 Jul 2017 - 5 Oct 2021
Closed
GRANT
Laboratory Studies of Acute Lymphoblastic Leukemia
Cell Works Group, Inc6 Jul 2017 - 31 May 2018
Expired
GRANT
DRPD-R0F2017: An Integrated Multi-'omics' Analysis of Myelodysplastic Syndromes
UF DSR Opportunity Fund27 Apr 2017 - 31 May 2021
Expired
GRANT
A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent
Onconova Therapeutics23 Aug 2016 - 24 Aug 2021
Closed

DrChristopher Cogle

GRANTS